[PLX] QoQ Quarter Result on 31-Dec-2010 [#Q4]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
23-Feb-2011
Financial Year
2010
Quarter
31-Dec-2010 [#Q4]
Profit Trend
QoQ- -244.70%
YoY- 42.90%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Revenue 1,132 764 6,000 1,176 3,184 1,141 1,141 -0.52%
PBT 0 179 -5,052 22,414 0 0 -7,955 -
Tax 108 20,699 0 -20,470 -374 -109 0 -
NP -8,875 -13,689 -5,052 -8,528 -2,474 -10,041 -7,955 7.56%
Tax Rate - -11,563.69% - 91.33% - - - -
Total Cost 10,007 14,453 11,052 9,704 5,658 11,182 9,096 6.56%
Ratio Analysis
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
NP Margin -784.01 -1,791.75 -84.20 -725.17 -77.70 -880.02 -697.20 8.12%
Per Share
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
EPS -0.10 -0.16 -0.06 -1.04 -0.03 -0.12 -0.10 0.00%
EPS Diluted -0.10 -0.16 -0.06 -1.04 -0.03 -0.12 -0.10 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.